DSM-5 Diagnosis definition

DSM-5 Diagnosis. A substance abuse diagnosis, as set forth in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, shall be required for program admission. The County may refer or authorize client services, or clients may self-refer.
Sample 1Sample 2Sample 3
DSM-5 Diagnosis means the diagnosis, consistent with the Fifth Edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), resulting from the clinical Assessment of a Member.
Sample 1Sample 2

Examples of DSM-5 Diagnosis in a sentence

  • The Diagnosis should be available at the time of admission, as the existence of a DSM-5 Diagnosis is one of the admission criteria.

  • If soldiers obtain a high GSI (i.e., 2 standard deviations above the mean), then further assessment will verify symptom severity using instruments such as the Beck Depression Inventory (BDI-II; Beck, Steer, & Brown, 1996) or the Beck Anxiety Inventory (BAI; Beck & Steer, 1993).PTSD Checklist for DSM-5 Diagnosis.

  • Helpful Notes:Organize your paper using the categories listed above as paper headings: Life-Stage Theory; Risk and Resilience; Systems-Level Impacts, and DSM-5 Diagnosis.

  • Classification Quality of the PCL-5 for the DSM-5 Diagnosis of PTSDScore≥Note.

  • Harris & Stephen Greenspan, DSM-5: Diagnosis of Intellectual Disability and the “Relatedness” Phrase, 42 Psychol.

  • The renaming of mental retardation: Understanding the change to the DSM-5: Diagnosis of intellectual disability and the “relatedness” phraseMarc J.

  • Primary MCCB composite score summaries will be repeated for the following subgroups: 1-) Current Primary DSM-5 Diagnosis (schizophrenia and schizophreniform); 2-) Subjects who continued into Part III and those who did not.

  • During my combinedchild psychiatry/neurodevelopmental pediatrics fellowship training I read Barbel Inhelder’s Diagnoses of reasoning in the mental retarded and began to reflect about the prospect that DSM-5: Diagnosis of intellectual disability and the “relatedness” phraseMarc J.

  • In Part II, primary time to treatment failure summaries will be repeated for the following subgroups: 1-) Current Primary DSM-5 Diagnosis (schizophrenia and schizophreniform); 2-) Subjects who continued into Part III and those who did not.

  • Assessment of a Modified DSM-5 Diagnosis of Alcohol Use Disorder in a Genetically Informative Population.

Related to DSM-5 Diagnosis

  • Diagnosis means the definition of the nature of the Client's disorder. When formulating the Diagnosis of Client, CONTRACTOR shall use the diagnostic codes and axes as specified in the most current edition of the DSM published by the American Psychiatric Association. DSM diagnoses will be recorded on all IRIS documents, as appropriate.

  • COVID-19 symptoms means fever of 100.4 degrees Fahrenheit or higher, chills, cough, shortness of breath or difficulty breathing, fatigue, muscle or body aches, headache, new loss of taste or smell, sore throat, congestion or runny nose, nausea or vomiting, or diarrhea, unless a licensed health care professional determines the person’s symptoms were caused by a known condition other than COVID-19.

  • Diagnosis of autism spectrum disorder means medically necessary assessments, evaluations, or tests

  • Medical cannabis pharmacy means the same as that term is defined in Section 26-61a-102.

  • Psychotropic medication means medication the prescribed intent of which is to affect or alter thought processes, mood, or behavior including but not limited to anti-psychotic, antidepressant, anxiolytic (anti-anxiety), and behavior medications. The classification of a medication depends upon its stated, intended effect when prescribed.

  • Nursing diagnosis means a judgment made by a registered nurse, following a nursing assessment of individuals and groups about actual or potential responses to health problems, which forms the basis for determining effective nursing interventions.

  • Medical cannabis means the same as that term is defined in Section 26-61a-102.

  • sickle cell disease means a hemolytic disorder characterized by chronic anemia, painful events, and various complications due to associated tissue and organ damage; "hemolytic" refers to the destruction of the cell membrane of red blood cells resulting in the release of hemoglobin.

  • Phase 2 Clinical Trial means a human clinical trial, for which the primary endpoints include a determination of dose ranges or an indication of efficacy in patients being studied as described in 21 C.F.R. §312.21(b), or an equivalent clinical trial in a country in the Territory other than the United States.

  • Clinical laboratory means a facility for the microbiological, serological, chemical, hematological, radiobioassay, cytological, immunohematological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of a disease or assessment of a medical condition.

  • Clinical means having a significant relationship, whether real or potential, direct or indirect, to the actual rendering or outcome of dental care, the practice of dentistry, or the quality of dental care being rendered to a patient;

  • Phase II Clinical Trial means a controlled human clinical study that would satisfy the requirements of 21 CFR 312.21(b), conducted to study the effectiveness and establish the dose range of a Product for a particular Indication in patients with the disease or condition under study, including a Phase IIA Clinical Study or Phase IIB Clinical Study.

  • Disease means an alteration in the state of the body or of some of its organs, interrupting or disturbing the performance of the functions, and causing or threatening pain and weakness or physical or mental disorder and certified by a Medical Practitioner.

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Study means the investigation to be conducted in accordance with the Protocol.

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.

  • Testing laboratory means a laboratory, facility, or entity in the state that offers or performs tests of cannabis or cannabis products and that is both of the following:

  • Cardiopulmonary resuscitation or "CPR" means artificial ventilation or external chest compression applied to a person who is unresponsive and not breathing.

  • Medication means any drug, chemical, compound, suspension, or preparation in suitable form for use as a curative or remedial substance taken either internally or externally by any person.

  • Medical history means information regarding any:

  • Medical cannabis card means the same as that term is defined in Section 26-61a-102.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Phase 4 Clinical Trial means a Clinical Trial of a Product conducted after Regulatory Approval of such Product has been obtained from an appropriate Regulatory Authority, which trial is (a) conducted voluntarily by a Party to enhance marketing or scientific knowledge of the Product, or (b) conducted due to a request or requirement of a Regulatory Authority.

  • Antipsychotic medications means that class of drugs